Fig. 3From: The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysisOverall survival with (blue) or without (red) adjuvant immunotherapy for (a) all patients with only adjuvant therapies; b patients who received adjuvant chemotherapy or adjuvant chemoradiationBack to article page